The role of biomarkers in personalized immunotherapy
Abstract Background Immune checkpoint inhibitors have revolutionized cancer therapeutic paradigm and substantially improved the survival of patients with advanced malignancies. However, a significant limitation is the wide variability in clinical response. Main text Several biomarkers have been eval...
Saved in:
Main Authors: | Kamya Sankar (Author), Jing Christine Ye (Author), Zihai Li (Author), Lei Zheng (Author), Wenru Song (Author), Siwen Hu-Lieskovan (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel strategies for immuno-oncology breakthroughs with cell therapy
by: Hongtao Liu, et al.
Published: (2021) -
Cuproptosis-Related Genes as Prognostic Biomarkers for Sepsis: Insights into Immune Function and Personalized Immunotherapy
by: Zhang J, et al.
Published: (2024) -
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
by: Rilan Bai, et al.
Published: (2020) -
Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy
by: Weijie Cao, et al.
Published: (2022) -
Magnesium-related gene ITGAL: a key immunotherapy predictor and prognostic biomarker in pan-cancer
by: Fengjie Lin, et al.
Published: (2024)